245 related articles for article (PubMed ID: 8721285)
1. Monitoring of plasma clozapine levels and its metabolites in refractory schizophrenic patients.
Liu HC; Chang WH; Wei FC; Lin SK; Lin SK; Jann MW
Ther Drug Monit; 1996 Apr; 18(2):200-7. PubMed ID: 8721285
[TBL] [Abstract][Full Text] [Related]
2. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
Spina E; Avenoso A; Facciolà G; Scordo MG; Ancione M; Madia AG; Ventimiglia A; Perucca E
Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
[TBL] [Abstract][Full Text] [Related]
3. Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia: association with response.
Piscitelli SC; Frazier JA; McKenna K; Albus KE; Grothe DR; Gordon CT; Rapoport JL
J Clin Psychiatry; 1994 Sep; 55 Suppl B():94-7. PubMed ID: 7961584
[TBL] [Abstract][Full Text] [Related]
4. Another use of silica gel and aqueous eluent for HPLC analysis of clozapine and desmethylclozapine.
Coudoré F; Nicolay A; Hoareau M; Eschalier A
J Anal Toxicol; 1999; 23(3):195-9. PubMed ID: 10369329
[TBL] [Abstract][Full Text] [Related]
5. Effect of treatment duration on plasma levels of clozapine and N-desmethylclozapine in men and women.
Fabrazzo M; Esposito G; Fusco R; Maj M
Psychopharmacology (Berl); 1996 Mar; 124(1-2):197-200. PubMed ID: 8935816
[TBL] [Abstract][Full Text] [Related]
6. Sexual disturbances during clozapine and haloperidol treatment for schizophrenia.
Hummer M; Kemmler G; Kurz M; Kurzthaler I; Oberbauer H; Fleischhacker WW
Am J Psychiatry; 1999 Apr; 156(4):631-3. PubMed ID: 10200746
[TBL] [Abstract][Full Text] [Related]
7. Whole saliva and plasma levels of clozapine and desmethylclozapine.
Dumortier G; Lochu A; Zerrouk A; Van Nieuwenhuyse V; Colen de Melo P; Roche Rabreau D; Degrassat K
J Clin Pharm Ther; 1998 Feb; 23(1):35-40. PubMed ID: 9756110
[TBL] [Abstract][Full Text] [Related]
8. Correlation Between Serum Concentrations of N-Desmethylclozapine and Granulocyte Levels in Patients with Schizophrenia: A Retrospective Observational Study.
Smith RL; Haslemo T; Andreassen OA; Eliasson E; Dahl ML; Spigset O; Molden E
CNS Drugs; 2017 Nov; 31(11):991-997. PubMed ID: 28948574
[TBL] [Abstract][Full Text] [Related]
9. Clozapine and desmethylclozapine: correlation with neutrophils and leucocytes counting in Mexican patients with schizophrenia.
Vaquero-Baez M; Díaz-Ruíz A; Tristán-López L; Aviña-Cervantes C; Torner C; Ramírez-Bermúdez J; Montes S; Ríos C
BMC Psychiatry; 2019 Oct; 19(1):295. PubMed ID: 31597566
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic-resistant schizophrenic patients treated by clozapine: clinical evolution, plasma and red blood cell clozapine and desmethylclozapine levels.
Aymard N; Baldacci C; Leyris A; Smagghe PO; Tribolet S; Vacheron MN; Viala A; Caroli F
Therapie; 1997; 52(3):227-32. PubMed ID: 9366107
[TBL] [Abstract][Full Text] [Related]
11. Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking.
Hasegawa M; Gutierrez-Esteinou R; Way L; Meltzer HY
J Clin Psychopharmacol; 1993 Dec; 13(6):383-90. PubMed ID: 8120151
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations.
Llorca PM; Lancon C; Disdier B; Farisse J; Sapin C; Auquier P
J Psychiatry Neurosci; 2002 Jan; 27(1):30-7. PubMed ID: 11836974
[TBL] [Abstract][Full Text] [Related]
13. Higher plasma drug concentration in clozapine-treated schizophrenic patients with side effects of obsessive/compulsive symptoms.
Lin SK; Su SF; Pan CH
Ther Drug Monit; 2006 Jun; 28(3):303-7. PubMed ID: 16778711
[TBL] [Abstract][Full Text] [Related]
14. Correlation of antipsychotic and prolactin concentrations in children and adolescents acutely treated with haloperidol, clozapine, or olanzapine.
Alfaro CL; Wudarsky M; Nicolson R; Gochman P; Sporn A; Lenane M; Rapoport JL
J Child Adolesc Psychopharmacol; 2002; 12(2):83-91. PubMed ID: 12188977
[TBL] [Abstract][Full Text] [Related]
15. Reduction of clozapine-induced hypersalivation by pirenzepine is safe.
Schneider B; Weigmann H; Hiemke C; Weber B; Fritze J
Pharmacopsychiatry; 2004 Mar; 37(2):43-5. PubMed ID: 15048609
[TBL] [Abstract][Full Text] [Related]
16. Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients.
Kronig MH; Munne RA; Szymanski S; Safferman AZ; Pollack S; Cooper T; Kane JM; Lieberman JA
Am J Psychiatry; 1995 Feb; 152(2):179-82. PubMed ID: 7840349
[TBL] [Abstract][Full Text] [Related]
17. Automated determination of clozapine and major metabolites in serum and urine.
Weigmann H; Bierbrauer J; Härtter S; Hiemke C
Ther Drug Monit; 1997 Aug; 19(4):480-8. PubMed ID: 9263393
[TBL] [Abstract][Full Text] [Related]
18. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
[TBL] [Abstract][Full Text] [Related]
19. Plasma clozapine levels and clinical response in treatment-refractory Chinese schizophrenic patients.
Wong JO; Leung SP; Mak T; Ng RM; Chan KT; Hon-Kee Cheung H; Choi WK; Lai J; Wai-Kiu Tsang A
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):251-64. PubMed ID: 16316716
[TBL] [Abstract][Full Text] [Related]
20. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients.
Perry PJ; Miller DD; Arndt SV; Cadoret RJ
Am J Psychiatry; 1991 Feb; 148(2):231-5. PubMed ID: 1670979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
